TELADOC HEALTH INC
TDOCNYSETrading Snapshot
- Day Range
- $7.90 β $8.99
- 52-Week Range
- $4.40 β $9.89
- Volume (shares)
- 7,679,336
- Avg Volume (shares)
- β
- Shares Outstanding
- 181.7M
- Next Earnings
- 2027-02-23
Fundamentals Snapshot
- Annual Revenue
- $2.53B
- Last Q Revenue
- $605M
- P/E Ratio
- -8.0
- P/S Ratio
- 0.5x
- EPS (TTM)
- $-0.85
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +2.0%
TELADOC HEALTH INC
TDOCAbout TELADOC HEALTH INC
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Latest News & Updates

Teladoc Stock Rallies After Double Beat; Lifts FY26 GAAP EPS Outlook
Teladoc Health Inc. (NYSE:TDOC) shares are trading higher Thursday after the company reported better-than-expected third-quarter financial results Wednesday after the market closed and raised its 2026 GAAP earnings per s

Teladoc Health, Inc. (TDOC) Q3 2026 Earnings Call Transcript
Teladoc Health, Inc. (TDOC) Q3 2026 Earnings Call Transcript

Cathie Wood Is Buying Archer Aviation Stock. Here's What History Says About Following Ark Into a Stock Down 62%.
Should investors follow Wood's lead with this eVTOL manufacturer?

Teladoc Health Q3 Earnings Call Highlights
Teladoc Health NYSE: TDOC reported third-quarter 2026 revenue near the upper end of its guidance range and adjusted EBITDA above expectations, as growth in Integrated Care and BetterHelp insurance revenue partly offset c

Teladoc: 3 Key Takeaways for Long-Term Investors
Third-quarter consolidated revenue reached $605 million. BetterHelp insurance revenue reached $32 million in the third quarter.

Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-a